UNITY Biotechnology to Present at the ARVO 2025 Annual Meeting

GlobeNewswire
2025.05.01 12:33
portai
I'm PortAI, I can summarize articles.

SOUTH SAN FRANCISCO, Calif., May 01, 2025 ( GLOBE NEWSWIRE ) -- UNITY Biotechnology, Inc. ( "UNITY" ) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt or reverse diseases of aging, today announced that the Company will present 36-week data from the ASPIRE Phase 2B ...

Source: GlobeNewswire The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
© 2026 Longbridge｜Disclaimer